SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-22-034509
Filing Date
2022-03-16
Accepted
2022-03-16 16:20:55
Documents
6
Effectiveness Date
2022-03-16

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm229110d1_s8.htm S-8 50735
2 EXHIBIT 5.1 tm229110d1_ex5-1.htm EX-5.1 11247
3 EXHIBIT 23.1 tm229110d1_ex23-1.htm EX-23.1 2239
4 EX-FILING FEES tm229110d1_ex-filingfees.htm EX-FILING FEES 18232
5 GRAPHIC tm229110d1_ex5-1img01.jpg GRAPHIC 9149
6 GRAPHIC tm229110d1_ex5-1img02.jpg GRAPHIC 5447
  Complete submission text file 0001104659-22-034509.txt   103968
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263609 | Film No.: 22745158
SIC: 2834 Pharmaceutical Preparations